[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[no subject]
- From: JOHANNES VELTEROP@lists.yale.edu
- Date: Tue, 20 Apr 2004 12:42:56 -0400 (EDT)
<velteropvonleyden@btinternet.com> To: liblicense-l@lists.yale.edu Subject: Re: Reed Elsevier CEO comments X-edited-by: liblicen@pantheon.yale.edu Date: Tue, 20 Apr 2004 12:39:44 EDT Reply-To: liblicense-l@lists.yale.edu Sender: owner-liblicense-l@lists.yale.edu X-Listprocessor-Version: 8.2 -- ListProc(tm) by CREN Precedence: bulk Crispin Davis is just repeating the tired old myths he also propounded in the UK House of Commons hearings on STM publishing in early March. For an exposure of his myths and others that are being used to try to discredit Open Access, see: <http://www.biomedcentral.com/openaccess/inquiry/myths/> Jan Velterop ____ "Joseph J. Esposito" <espositoj@worldnet.att.net> wrote: An article on journals publishing from the Reed Elsevier CEO. Joe Esposito **** >Why the sci-mag barons are right In March The Observer's Simon Caulkin argued that scientific publishers had long used their stranglehold on the market to push up prices at the expense of underfunded academics. This, he suggested, was about to be changed by the welcome arrival of 'open access' publishing. Here, Crispin Davis, chief executive of leading publisher Reed Elsevier defends the industry Sunday April 18, 2004 The Observer Vigorous debate is a sign that scientific research is working well; bold ideas that challenge existing approaches - and their refinement through experiments - are drivers of scientific progress. [SNIP]
- Prev by Date: Re: Reed Elsevier CEO comments
- Next by Date: Re: How to fund open access journals from available sources
- Previous by thread: Reed Elsevier CEO comments
- Next by thread: Picking up on Ann's comment
- Index(es):